We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

120 hedge funds and large institutions have $657M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 22 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 22

0.14% more ownership

Funds ownership: 21.79%21.93% (+0.14%)

9% less funds holding

Funds holding: 132120 (-12)

36% less call options, than puts

Call options by funds: $3.45M | Put options by funds: $5.36M

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

40% less funds holding in top 10

Funds holding in top 10: 106 (-4)

64% less capital invested

Capital invested by funds: $1.83B → $657M (-$1.17B)

Holders
120
Holders Change
-12
Holders Change %
-9.09%
% of All Funds
1.89%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
17
Increased
58
Reduced
22
Closed
28
Calls
$3.45M
Puts
$5.36M
Net Calls
-$1.91M
Net Calls Change
-$2.33M
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$4.69M +$97K +3,786 +1%
Norges Bank
27
Norges Bank
Norway
$4.37M +$4.77M +186,133 +224%
ICP
28
Indus Capital Partners
New York
$4.27M +$2.6M +101,393 +63%
Franklin Resources
29
Franklin Resources
California
$4.15M +$5.56K +217 +0.1%
Legal & General Group
30
Legal & General Group
United Kingdom
$4.04M +$540K +21,071 +9%
Barclays
31
Barclays
United Kingdom
$3.91M +$6.17M +240,881 New
Handelsbanken Fonder
32
Handelsbanken Fonder
Sweden
$3.66M -$769K -30,000 -12%
EPL
33
EDBI Pte Ltd
Singapore
$3.61M
UBS AM
34
UBS AM
Illinois
$3.31M -$179K -6,995 -3%
ZAM
35
Zeal Asset Management
Hong Kong
$3.25M -$30.5M -1,190,286 -86%
PCIG
36
Partners Capital Investment Group
Massachusetts
$3.19M +$2.19M +85,380 +77%
Millennium Management
37
Millennium Management
New York
$2.94M +$2.88M +112,374 +163%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$2.93M +$154K +6,017 +3%
Deutsche Bank
39
Deutsche Bank
Germany
$2.75M +$276K +10,777 +7%
TCM
40
Tekla Capital Management
Massachusetts
$2.64M
Two Sigma Advisers
41
Two Sigma Advisers
New York
$2.49M +$3.93M +153,400 New
T
42
TOBAM
France
$2.44M -$1.14M -44,300 -23%
IBT
43
International Biotechnology Trust
United Kingdom
$2.38M
HSBC Holdings
44
HSBC Holdings
United Kingdom
$2.24M +$1.14M +44,337 +48%
Renaissance Technologies
45
Renaissance Technologies
New York
$2.23M -$2.24M -87,400 -39%
Capital Fund Management (CFM)
46
Capital Fund Management (CFM)
France
$2.09M +$2.75M +107,383 +500%
OWP
47
Old Well Partners
North Carolina
$2.06M +$620K +24,200 +24%
JP Morgan Chase
48
JP Morgan Chase
New York
$1.89M +$2.92M +113,787 +4,842%
O
49
OrbiMed
New York
$1.8M
CSS
50
Cubist Systematic Strategies
Connecticut
$1.72M +$2.71M +105,599 +19,412%

NBP Hedge Fund Activity: Q1 2022 in Review

120 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2022, worth a combined $657M — down 64% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NBP and 17 opened new positions — a net loss of 11 holders — while 22 trimmed existing stakes and 58 added.

The largest buyer was Artisan Partners, adding an estimated $26M. The largest seller was T. Rowe Price Associates, cutting an estimated $50.1M.

  • 120 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2022, down from 132 in Q4 2021.
  • Funds reported $657M of NovaBridge Biosciences American Depositary Shares stock for Q1 2022, down 64% quarter-over-quarter.
  • 17 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2022 and 28 closed out, a net change of -11 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2022 was Artisan Partners, an estimated $26M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2022 was T. Rowe Price Associates, an estimated $50.1M sold.

Based on aggregated 13F filings for Q1 2022.